Tuesday, April 25, 2017

Quieting the heart murmur and the "nay-sayers"

After my second and more severe bout with cancer, mega chemotherapy treatments and my failure with 2 anti-cancer drugs, I was ready to try an alternative method. Megan Van Zyl came highly recommended to me and we connected. Since using her regimen to cleanse and improve my immune system, I not only feel wonderful but my thyroid TSH levels, which was at 0.04 is now 2.28 (in the normal range for the first time in a long time!!), and my heart murmur, which you could hear without a stethoscope, is hardly audible. After 4 months not knowing if the effort was achieving any significant results, I am ecstatic, to say the least, but have also quieted the “nay-sayers” in my family. All I can say, is “IT WORKS!!!” and “THANK YOU!!!!”
 

Bonnie Nardinger, Great Falls, MT

Bonnie came to me struggling with intense hot flashes, low thyroid function and many other side effects from conventional cancer treatment methods.  As many of my clients come, she felt awful and wanted to feel better and to gain confidence that cancer would not be coming back a 3rd time!  How someone feels during treatment shouldn't have anything to do with survival outcomes?  Let's look at a prominent study from the 1980s to understand the answer to this question.

A study in 1980 was published in The Journal of National Cancer Institute by Stanley and colleagues that should have shifted the entire philosophy and approach to cancer treatment, but has yet to be acknowledged by the vast majority of oncologists and the cancer industry as a whole.  This is truly a landmark study that deserves our attention and understanding.

In this particular study, 5,000 patients with inoperable lung cancer were tracked over a 10-year period in order to ascertain what factors would contribute to survival outcomes in poor prognosis patients. There were 77 different factors considered throughout this 10-year study including tumor size, histological type of cancer, clinical status, etc.

When this study was being conducted through 1980-1990, the NCI had a very stringent, narrow definition of positive response to a treatment.  In their definition, patients with total regression of tumors that lasted at least four weeks and a significant partial response of at least 50% tumor regression lasting at least four weeks as well.  The clinical status and survival did not account for anything, soley tumor shrinkage, even in the face of death.

Surprisingly (to some), the single most important factor was not tumor shrinkage; rather, patients who felt good and could do more things for themselves had far better survival outcomes than those who felt worse and did less for themselves.

Did this study have any impact on the NCI's definition of a positive response to treatments?  Not really.  The general approach is still to attack the cancer cells in aggressive treatments in order to shrink the tumor small enough to be removed through surgery.  However, this study from the 1980s proved that tumor shrinkage was not heavily correlated with survival outcomes.   How could the results of this study be missed by our medical establishment?

The definition and basic assumptions of what contributes to survival outcomes seems to be impairing the improvement in long-term survival outcomes for cancer patients undergoing aggressive, potentially dangerous treatments all in the effort to shrink the tumors.


Many times, I work with clients who have gone through chemotherapy and other aggressive treatments who want to detoxify and ensure that the cancer will not come back again more aggressively.  Bonnie was such a client. Through all the ups and downs, she is at a wonderful place in her health, confident that the cancer will not come back and that she has been able to address the root causes to the development of cancer in her body.  She is thoroughly confident that cancer will not be returning a 3rd time and feels compelled to share her story of healing with the world! Thanks Bonnie, enjoy your newfound health!  

If you would like to order a copy of my new book to learn more about What is Cancer and why it develops in the body, 
click http://amzn.to/2mMiHGS to purchase my book or to read over kindle/E-book.


If you are a holistic health practitioner and you want to grow in your clinical and business knowledge to be able to achieve clarity and confidence in your practice, reach out to me @ yourgreenumbrella@gmail.com.  The next Green Umbrella Professional Training Program will be starting in June 2017 and we would love to have you join! For more
information:  http://www.yourgreenumbrella.com/course.php If you or a loved one has cancer and would like to work with a Nutritional Therapist, please email me at yourgreenumbrella@gmail.com.  We are currently taking new clients.  


Disclaimer:  The Green Umbrella does not diagnose, treat, or cure any disease.  Consult your doctor if you suspect that you have a disease or need medical attention.  

Tuesday, April 18, 2017

Hidden studies & cancer breakthroughs

Dr. John Beard who first discovered that the trophoblast cells of the placenta mirrored the undifferentiated, primitive cancer cells, extensively studied the clinical use of trypsin and amylase in cancer treatment.  Trypsin was named by German scientist, W. Kuhne in 1867.  In Greek trypsin means "I wear away" to demonstrate the intense metabolic activity of this enzyme.  Trypsin was first used in treatment of diphtheria.  Diphtheria bacteria produces a thick membrane in the throat that could lead to suffocation.  Injectable trypsin digested this membrane in animals exposed to the bacteria.

Dr. John Beard explored the injectable form of pancreatic enzymes and its clinical use in cancer treatments. The therapeutic use of pancreatic enzymes was a delicate scientific process because trypsin was highly active to the point of self-destruction if extraction methods were not done with exacting precision.

In fact, because of the need for precise methods, Beard became involved in the manufacturing process of the enzymes.  He assisted Fairchild in the process necessary to extract the highest amount of pancreatic enzymes without the loss of enzymes from self-combustion.  When Beard believed that they developed the highest potency injectable enzyme therapy, he began to experiment with animals.

The Jensen mouse tumors were clinically sound and available for use in cancer research in the early 1900s.  Beard began experimenting with using injectable trypsin in isolation and in combination with amylase.  When Beard used trypsin in isolation with too high of a dose in animals with cancer, he would see the animals die quickly.  He postulated that the animals were dying because of the high amounts of toxins being released while the tumor was being digested by the enzymes.

Thus, Beard began to experiment with trypsin injections followed by injections of amylase for several days.  He found the animals thriving in their recovery as amylase helped to clear the excess toxins from the destruction that trypsin had upon the tumor mass.

In 1906, The British Medical Journal published the first successes with enzyme therapy in the Jensen mouse tumor models.  Beard attracted a lot of positive and negative reactions from his work.  In fact, he had doctors critiquing every detail of his work down to questioning whether the mice had cancer in the first place.  They were incredulous that Beard would have discovered a cancer cure. 

However, despite the attacks, Beard continued forward to research his therapy on human patients.  In the first human trial, Beard used everything he learned from study with mice on human patients that failed conventional treatments.  He used 1,000 units of trypsin and 2,000 units of amylase in the injectable form daily. Physicians who used the proper dosing and proper approach reported great results.

Because of Beard's success, drug companies between 1906-1910 created and marketed their own enzyme preparations in a very sloppy, unscientific manner. Physicians using preparations outside of the Fairchild preparations influenced by Beard himself, found little success.  Some physicians used the Fairchild preparations with the wrong dosage or without amylase.

The cancer world hotly debated Beard's work and with the new flurry of activity surrounding radiation therapy, many physicians and researchers abandoned enzyme therapy without doing due diligence and with no regard to Beard's lifelong landmark discoveries.  In 1969, The U.S. Food and Drug Administration issued an order to outlaw the manufacturing and clinical usage of injectable pancreatic enzymes.  It would seem that Beard's work would die without advantage in clinical use for desperate cancer patients.  However, the good news is that injectable formula's of pancreatic enzymes are now on the rise, especially in Germany.

1.  Gonzalez, Nicholas J.  Nutrition And The Autonomic Nervous System.  The Scientific Foundations of The Gonzalez Protocol.


Tuesday, April 11, 2017

Hidden cancer cures and the landmark studies

We will continue down the path of exploring hidden cancer cures and the landmark studies which back their significance.  Dr. Pottenger was well known for his work in comparing raw diets to cooked diets in cats.  However, he is less known for his remarkable research surrounding the autonomic nervous system and the development of disease.  Dr. Pottenger commanded great attention to detail and mastery of understanding of the physiology of the body and how an imbalance in the autonomic nervous system could lead to debilitating disease (1).

The hypothalamus is the control center in the autonomic nervous system and a key component of the limbic system:  where mind, body and soul converge.  In the posterior hypothalamus, we find the parasympathetic nervous system.  In the anterior hypothalamus, we find the sympathetic nervous system.  These systems are connected with a feedback loop through the central nervous system.

Dr. Kelly found that breast cancer patients tended towards sympathetic nervous system dominance and that calcium supplementation became dangerous to breast cancer patients because it is a stimulant for the sympathetic nervous system.  In large doses, a heart attack could be induced when their body is operating out of an overactive sympathetic state.

The majority of people are balanced in their autonomic nervous system.  However, 10-20% of people are either sympathetic or parasympathetic dominant.  The characteristics of a sympathetic system being largely in control with no inter-system homeostasis would be the following:

1.  A highly developed heart
2.  Muscles well-defined regardless of exercise schedule
3.  Strong tendency towards reliance on the left hemisphere of the brain
4.  Overactive endocrine glands

Even certain personality traits can be correlated with sympathetic dominance; including:

1.  Tendency to be anxious and irritable
2.  Moments of aggression and hostility
3.  Well-disciplined and good at routines
4.  Tendency to be thin
5.  Not dependent on high quantities of sleep, only needing 6-8 hours
6.  Poor digestion

In a strong parasympathetic nervous system and weak sympathetic, the right hemisphere of the brain dominates as the digestive tract, pancreas and liver are overly active.   Organs and glands typically regulated by the sympathetic system are sluggish including heart, muscles, endocrine and thyroid glands.  Some of the personality traits of a parasympathetic nervous system dominant person would be:

1.  Person is typically calm and emotionally stable
2.  Slow to anger and not hot-tempered like a person who expresses sympathetic dominant
3.  Prone to depression
4.  A tendency to be undisciplined and more creative
5.  Easily becomes overweight

In order to balance the autonomic nervous systems, the proper nutritional stimulants must be used to strengthen the weakness and bring homeostasis.  Magnesium acts on the autonomic nervous system through suppressing an overactive sympathetic system.  During times of high stress and trauma, supplementing high doses of magnesium could help to maintain some balance between the autonomic nervous systems.  Potassium is a mineral which acts to stimulate the parasympathetic nervous system. Calcium can be used therapeutically when a person is parasympathetic dominant and needs the sympathetic system to be triggered.

Dr. Kelly and Dr. Pottenger made significant findings in regards to treating cancer as an autonomic nervous system imbalance.  Further, Dr. Kelly acting upon the research of Dr. John Beard, found that pancreatic proteolytic enzymes were necessary to remove the negatively charged protein coating on cancer cells.

Dr. John Beard discovered that almost 2 months after conception, the fetus began to create pancreatic enzymes.  Why were they needed?  A fetus survives soley on the nutrients from the mother and technically does not need enzymes to be released by the pancreas until the first time it breast feeds outside of the womb.  Dr. John Beard discovered that the pancreatic proteolytic enzymes were necessary to stop the invasion of the trophoblast cells in the development of the placenta.  Further, he found that the undifferentiated trophoblast cells of the placenta appeared the same as cancer cells.

Through many years of extensive research, Dr. Beard boldly claimed that uncontrolled cancer growth was not so different from the growth of the placenta and that supplementing high doses of proteolytic enzymes would help to break apart a tumor.  In many studies, his work has been confirmed and yet this cure for cancer has remained hidden for the majority of the world.

A particular landmark study found that pancreatic enzymes decreased side effects of conventional treatments including nausea, digestion issues, fatigue, weight loss and restlessness.  In specifically plasmacytoma cancer patients, enzyme therapy increased response rates, duration of remissions and overall survival outcomes (2).  The outcome of this study upgraded enzyme therapy to the "orphan drug status (3)."  An orphan drug is one that is not profitable for pharmaceutical companies and only treats in uncommon diseases.  Most holistic cancer treatments have not been approved or acknowledged despite the research backing their significance.  The fact that pancreatic enzyme therapy has been recognized in this manner demonstrates the importance of enzyme therapy to positive cancer treatment outcomes.

Thus the hidden cancer cures of balancing the autonomic nervous system and supplementing high amounts of pancreatic enzymes prove to be important components of a preventative paradigm as well as a holistic treatment protocol for cancer.

1.  Gonzalez, Dr. Nicholas J.  Nutrition And The Autonomic Nervous System.

2.  https://www.ncbi.nlm.nih.gov/pubmed/19116226

3.  https://en.wikipedia.org/wiki/Orphan_drug

Tuesday, April 4, 2017

Without this critical nutrient, risk of breast cancer increased by 354%

Many important studies on cancer are sitting on the shelves of research libraries collecting dust and lying dormant on the internet with no clinical application in mainstream oncology. The debate between holistic oncology and western modern oncology continues, however, many holistic treatments are backed with solid research studies.  Let's continue to explore these landmark studies and attempt to turn the Titanic of modern oncology to scientifically sound treatment options.  



One particular deficiency has been studied over and over again, solidly confirmed as one of the most important nutrients in preventing the development of cancer.  This nutrient is the easiest to obtain in states like California and Florida and more difficult to obtain in Northern states and countries.  In fact, Dr. Joseph Mercola, speaker & author from the well-known blog Mercola.com, moved from Chicago to Florida in order to access more of Vitamin D. Why would a holistic doctor move from Chicago to Florida for access to the sun?
  
Let's explore some of the vital studies to understand the power of Vitamin D3.  At George's Hospital Medical School in London, Vitamin D production in breast tissue was found to be correlated to a reduction of risk in the future development of breast cancer (1).  In fact, women testing with low amounts of Vitamin D were found to increase their risk of breast cancer by 354% (Anticancer Research 26: 2573-80, 2006).  This is one reason why I recommend my clients with breast cancer to sunbath with their breast tissue open to the sun rays for 15-30 minutes per day.  One of my clients found a dramatic response to sun therapy.  During one sunbathing session, after 18 minutes, she literally felt her tumor revolt from the sun and shrink down into the breast tissue.  Just 400 IU of Vitamin D per day reduces the risk of pancreatic cancer by 43% (1).  

Why is there such a dramatic response such as the one of my client sunbathing?  In 1968, J.W. Blunt found the composition of Vitamin D that circulates the blood to be 25-OH-D3 (2).  Blunt and his colleagues discovered that 25-OH-D3 was created in the liver and kidneys and acts as a hormone in the body. The hormonal action of Vitamin D3 modulates the immune system and is received on receptor sites of some cancer cells specifically relegated to D3 (2).  

When an individual is exposed to Vitamin D from the sun (bare skin with no sun block and no sunglasses so that the body can register that it is in the sun), Vitamin D travels through blood into the liver where is transformed into a prohormone (5).  Next, the prohormone form travels to the kidneys where it becomes the active form, calcitriol (5).  The kidneys release calcitriol back into the blood where it regulates how the body uses calcium and phosphorus (5).
  

Receptors for calcitriol are found in the nucleus of cells, the brain, heart, skin, breast tissue, prostate gland and white blood cells of the immune system (6).  This is one reason why Vitamin D3 has been more critically linked to breast and prostate cancer although it does impact every type of cancer diagnosis because of its key role in balancing the immune system.  

In another clinical trial of D3, patients received a Vitamin D cream to apply on breast tumors. Professor Charles Coomes, the clinical oncologist in Charing Cross Hospital in London found 1/3 of tumors to respond effectively to this treatment (3).  A comparison study examining the lives of 133 breast cancer patients found that regular sunbathing (without burning) lowered the risk of breast cancer by 30-40% (4).    

Some may find it necessary to make the move to sun-rich states such as California and Florida in order to better access the healing therapy of the sun.  However, others may find an effective and therapeutic Vitamin D3 supplement.  Cod liver oil is a great supplemental source for Vitamin D3 and the easiest to assimilate because it is a food source.  However, not all cod livers oils and D3 supplements are created equal, so choose wisely and carefully. For example, don't buy a Walmart, GNC, or Target brand of Vitamin D3 and expect it to have a therapeutic effect.  

Learning from these landmark cancer studies, we can better prevent cancer in the lives of our families and clients.  Let us continue to press on and explore landmark cancer studies and eradicate cancer as the lifestyle onset disease that it is by reversing deficiencies, lessening our exposure to toxins and helping our body to heal and find proper balance.  

1.  Sardi, Bill.  You Don't Have to Be Afraid of Cancer Anymore. 

2.  Moss, Ralph W. Ph.D.  Cancer Therapy:  The Independent Consumer's Guide to Non-Toxic Treatment & Prevention.  

3.  Bartram, Thomas.  Bartram's Encyclopedia of Herbal Medicine:  The Definitive Guide.  

4.  Harkness, Richard.  The Natural Pharmacist:  Your Complete Guide to Reducing Cancer Risk.  

5.  https://www.cancertutor.com/vitamin-d-longer-breast-cancer-survival/

6.  Rubin, Alan L.  What is Vitamin D and How Does it Work?

7.  http://www.naturalnews.com/025495_Vitamin_D_brst_cancer.html